Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease

Papaefthymiou, Apostolis; Doulberis, Michael; Karafyllidou, Kyriaki; Chatzimichael, Eleftherios; Deretzi, Georgia; Exadaktylos, Aristomenis K.; Sampsonas, Fotios; Gelasakis, Athanasios; Papamichos, Spyros I.; Kotronis, Georgios; Gialamprinou, Dimitra; Vardaka, Elisabeth; Polyzos, Stergios A.; Kountouras, Jannis (2023). Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease. Minerva endocrinology, 48(3), pp. 346-359. Edizioni Minerva Medica 10.23736/S2724-6507.21.03564-8

Full text not available from this repository. (Request a copy)

Nonalcoholic fatty liver disease (NAFLD) was recently renamed to metabolic (dysfunction)-associated fatty liver disease (MAFLD) to better characterize its pathogenic origin. NAFLD represents, at least in western societies, a potential epidemic with raising prevalence. Its multifactorial pathogenesis is partially unraveled and till now there is no approved pharmacotherapy for NAFLD. A plethora of various choices are investigated in clinical trials, targeting an arsenal of different pathways and molecules. Since the mineralocorticoid receptor (MR) and renin-angiotensin-aldosterone system (RAAS) appear to be implicated in NAFLD, within this concise review, we focus on a rather classical and inexpensive pharmacological agent, spironolactone. We present the current lines of evidence of MR and RAAS-related preclinical models and human trials reporting an association with NAFLD. In conclusion, evidence about spironolactone of RAAS is commented, as potential future pharmacological management of NAFLD.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > University Emergency Center
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine

UniBE Contributor:

Doulberis, Michael, Exadaktylos, Aristomenis

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2724-6116

Publisher:

Edizioni Minerva Medica

Language:

English

Submitter:

Romana Saredi

Date Deposited:

08 Dec 2021 11:29

Last Modified:

20 Sep 2023 00:10

Publisher DOI:

10.23736/S2724-6507.21.03564-8

PubMed ID:

34669319

URI:

https://boris.unibe.ch/id/eprint/161911

Actions (login required)

Edit item Edit item
Provide Feedback